Daniel A. Laheru
Impact in
- Oncology top 0.05%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 209
- Pancreatic and Hepatic Oncology Research 167
- Cancer Immunotherapy and Biomarkers 40
- Colorectal Cancer Treatments and Studies 21
-
- Cancer Genomics and Diagnostics 63
- Co-authors
- Elizabeth M. JaffeeRalph H. HrubanJoseph M. HermanChristopher L. WolfgangEric R. LutzMark YarchoanManuel HidalgoLei Zheng
- Journals
- Journal of Clinical Oncology (48 papers)International Journal of Radiation Oncology*Biology*Physics (19 papers)Annals of Surgical Oncology (12 papers)Clinical Cancer Research (11 papers)Cancer Research (9 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Daniel A. Laheru
222 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 12.5k
- Cancer Research 4.0k
- Immunology 3.0k
- Pulmonary and Respiratory Medicine 3.7k
- Biotechnology 671
Countries citing papers authored by Daniel A. Laheru
This map shows the geographic impact of Daniel A. Laheru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Laheru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Laheru more than expected).
Fields of papers citing papers by Daniel A. Laheru
This network shows the impact of papers produced by Daniel A. Laheru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Laheru. The network helps show where Daniel A. Laheru may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Laheru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 19 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 64 | |
| 8 | 2020 | 69 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 91 | |
| 11 | 2019 | 180 | |
| 12 | PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers Hit paper breakdown → | 2019 | 386 |
| 13 | 2018 | 39 | |
| 14 | 2016 | 145 | |
| 15 | 2016 | 19 | |
| 16 | 2014 | 399 | |
| 17 | 2012 | 199 | |
| 18 | 2011 | 52 | |
| 19 | 2011 | 179 | |
| 20 | 2005 | 14 |
About Daniel A. Laheru
Daniel A. Laheru is a scholar working on Oncology, Cancer Research, Biotechnology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 230 papers that have together received 15.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (167 papers), Cancer Genomics and Diagnostics (63 papers), Neuroendocrine Tumor Research Advances (48 papers), Cancer Immunotherapy and Biomarkers (40 papers), Renal cell carcinoma treatment (25 papers), Colorectal Cancer Treatments and Studies (21 papers), Pancreatitis Pathology and Treatment (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). The work is most often cited by research in Oncology (12.5k citations), Cancer Research (4.0k citations), Immunology (3.0k citations), Pulmonary and Respiratory Medicine (3.7k citations) and Biotechnology (671 citations). Daniel A. Laheru has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Elizabeth M. Jaffee, Ralph H. Hruban, Joseph M. Herman, Christopher L. Wolfgang, Eric R. Lutz, Mark Yarchoan, Manuel Hidalgo, Lei Zheng, John L. Cameron and Burles A. Johnson. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Surgical Oncology, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.